Tuesday, 24 May, 2022
TopicSerum Institute of India

Topic: Serum Institute of India

Will supply 20 crore doses of Covishield in September, SII notifies Modi govt

In a production plan submitted to the Centre in May, SII’s director communicated that the production of Covishield would be ramped up to 10 crore each in August, September, said sources.

Serum Institute writes to Health Minister Mansukh Mandaviya to reform drug regulatory system

SII also sought permission to use the remaining quantities of batches of Covid and non-Covid vaccines for commercial purposes which have been used in the clinical trials.

SII to begin manufacturing Sputnik V in India by September, targets 300 million doses a year

Pune-based vaccine manufacturer SII has already received cell and vector samples for the production of Sputnik V from Russia's Gamaleya Center, the developer of the vaccine.

Serum Institute manufacturing 1st batch of Covovax Covid vaccine this week, says Poonawalla

SII CEO Poonawalla said the vaccine, developed by US company Novavax, has great potential to protect those below the age of 18 and trials are ongoing.

Covovax vaccine samples cleared by national drug lab, phase 3 trials could begin by July

Covovax, Novavax's Indian version, will be tested on 1,400 volunteers across 20 cities by Serum Institute, which has already begun production of the Covid vaccine.

Pune cell science centre could soon get Modi govt nod to test and approve Covid vaccines

If given a go-ahead, National Centre for Cell Science will be the 2nd centre after Central Drugs Laboratory, Kasauli, to test Covid-19 vaccines.

How setbacks at India’s Serum Institute have left the world short on Covid vaccines

SII's problems have become a key illustration of how the effort to inoculate developing world has failed, & a cautionary tale for becoming over-reliant on one manufacturer.

‘Same rules for everyone’: SII reiterates indemnity demand as govt negotiates with Pfizer

Modi government has so far stood firm on not offering indemnity to Covid vaccine makers. But vaccine shortage could force it reconsider as it negotiates with foreign companies.

Serum Institute seeks DCGI permission to manufacture Sputnik V vaccine

The SII has already told the government that it will be able to manufacture and supply 10 crore Covishield doses in June and is also manufacturing the Novavax vaccine.

Will be able to supply 10 crore Covishield doses in June –– Serum Institute tells Govt

In early May, SII had informed the Central govt that production of Covishield would be ramped up to 6.5 crore in June, 7 crore in July and 10 crore each in August and September.

On Camera


World’s $300 trillion in debt. Here’s what it means for services like health, education

To meet debt payments, at least 100 countries will have to reduce spending on essential services, the IMF estimates.


Boeing's F/A-18 Super Hornet pulls off its first successful launch from a ski-jump at Naval Air Station Patuxent River, US | Photo credit: Boeing

2 American Super Hornets in India as Boeing looks to showcase fighters for Navy deal

Navy looking at about 26 multi-role deck-based fighters for its aircraft carrier. Visit by Super Hornets comes close on heels of similar trip by competitor Rafale M of Dassault Aviation.

Mandir or Masjid? New surveys not needed, just acceptance of truth & move towards reconciliation

That temples were destroyed and mosques built is undisputed history. The past can’t be changed, but we can’t deny the wrongs of the past either before we consider reconciliation.